Climb Bio, Inc. (CLYM)
9.19
-0.09
(-0.97%)
USD |
NASDAQ |
Nov 20, 16:00
9.19
0.00 (0.00%)
After-Hours: 20:00
Climb Bio Cash and Short Term Investments (Annual) : 101.08M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 101.08M |
| December 31, 2024 | 150.92M |
| December 31, 2023 | 106.80M |
| December 31, 2022 | 123.57M |
| Date | Value |
|---|---|
| December 31, 2021 | 136.48M |
| December 31, 2020 | 20.49M |
| December 31, 2019 | 21.22M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Korsana Biosciences, Inc. | 3.24M |
| Cullinan Therapeutics, Inc. | 377.90M |
| Q32 Bio, Inc. | 48.30M |
| Oncolytics Biotech, Inc. | 5.202M |
| Sangamo Therapeutics, Inc. | 20.95M |